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Our initial view of genetic syndromes is often biased by
the collection of the most severely affected individuals
as a syndrome is first described. For genomic disorders,
which are caused by copy-number variation (CNV),
reduced penetrance and variable expression are almost
the rule rather than the exception, and fully delineating
this phenotypic variability is difficult, yet it is crucial for
genetic counseling. The design of a recent survey by
Ma¨nnik et al. gets around some of these issues through
the use of an unselected Estonian population for which
they had extensive health and education information.
Of the nearly 8,000 individuals included in their study,
56 were found to carry known, recurrent CNVs that cause
genomic disorders, such as 16p11.2 deletions and dupli-
cations. Although nobody in the cohort had previously
been diagnosed with a genetic disease, many had pheno-
types consistent with those described for the CNV they
carried. In addition, 10.5% of the population had rare
autosomal CNVs that were at least 250 kb in size. These
large deletions and duplications were associated with
an increased likelihood of having intellectual disability,
lower educational attainment, and a lower chance of
completing high school, implicating these rare CNVs
as a whole in variability in intelligence and success in
school. Although many of the genomic disorders are
said to have reduced penetrance, these data suggest
that CNVs might have an impact, even in individuals
who do not have a full-blown manifestation of the
disorder.
Ma¨nnik et al. (2015). JAMA 313, 2044–2054.
Panel-Based Breast Cancer Testing
The discussion of FDA regulation of genetic testing is
ramping up, and—whichever side of that argument you
fall on—it has increased the pressure to demonstrate
both clinical and analytical validity for genetic testing.
Among a recent set of special reports on genetic testing
in the New England Journal of Medicine is a paper by Easton
et al., who summarize evidence of the role of several genes
in breast cancer risk. Each diagnostic lab that offers this
type of test seems to include a different gene set (some
with upwards of 30 genes) on its cancer panels. In their
analysis, Easton et al. found evidence to support the inclu-
sion of only a small number of genes in personalized risk
prediction for breast cancer. Even among this group of1Department of Human Genetics, Emory University School of Medicine, Atlan
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overestimated, highlighting the need for well-designed
studies to optimize the utility of panel-based tests for
cancer risk.
Easton et al. (2015). N. Engl. J. Med. 372, 2243–2257.
Pass the Sunscreen
The Cancer Genome Atlas and other similar projects
have documented somatic mutations that occur in
various cancer types. From these mutational maps, one
can create evolutionary trees to understand retrospec-
tively which of these mutations most likely played an
important role in cancer initiation. One could instead
try to understand cancer from the opposite angle by
identifying somatic mutations in normal tissue to under-
stand how these mutations accumulate before a cancer
forms. In this vein, some work has been done with blood
cells; now, Martincorena et al. have used normal skin
samples from the eyelids of four individuals in order
to determine the mutational burden in normal, sun-
exposed skin. Through high-depth sequencing of 74
genes implicated in cancer, they identified a surprisingly
high number of somatic mutations in these samples: an
average of two to six per megabase of DNA per cell.
Indeed, they estimate that one-quarter of the cells
possess a cancer mutation. A significant excess of nonsy-
nonymous variation in particular genes suggests that
these include positively selected, driver mutations and
that, overall, the types of mutations observed are ex-
pected to occur via ultraviolet DNA damage. Thus, our
sun-exposed skin seems to be a hodge-podge of clones
that are at varying stages on the road to potential trans-
formation to cancer. Now, who would like some
sunscreen?
Martincorena et al. (2015). Science 348, 880–886.
Recombination Influences Segregation of Sister
Chromatids
Chromosomal recombination increases genetic diversity,
but it also ensures that homologous chromosomes segre-
gate properly during meiosis. Although recombination
maps have been generated from population studies and
in families that have had children with aneuploidy, these
studies don’t provide a complete picture of recombination
because they provide data from only one meiotic prod-
uct—the one that was successfully fertilized. Now, Ottolinita, GA 30322, USA
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et al. have used donated oocytes and embryos from an
in vitro fertilization clinic to assess recombination in the
complete set of meiotic products: the oocyte or embryo
and its corresponding polar bodies. They uncovered unex-
pected phenomena, including a role for recombination in
the segregation of sister chromatids, and discovered a not-
uncommon chromosomal segregation pattern in which
sister chromatids separate in meiosis I and non-sister
chromatids separate in meiosis II. This yields an oocyte
and second polar body with appropriate amounts of chro-
mosomal material but also a first polar body that contains
non-sister chromatids. The authors also uncovered a segre-
gation preference for non-recombinant chromatids in the
second polar body; this would help prevent the inheri-
tance of a large haplotype block directly from mother to
child.
Ottolini et al. (2015). Nat. Genet. Published online May 18,
2015. http://dx.doi.org/10.1038/ng.3306.4 The American Journal of Human Genetics 97, 3–4, July 2, 2015Major Role for Ciliary Defects in Congenital Heart
Disease
When one selects patients with congenital heart disease
(CHD)as the sample inwhich to seekgenes involved inheart
development, there is a potential bias toward less severemu-
tations that are compatible with a live birth. To avoid this
bias, Li et al. completed a massive forward screen in fetal
mice by performing ultrasounds on more than 80,000
fetal mice to identify a range of heart defects. Ultimately
recovering 218 models of CHD, the authors used exome
sequences to reveal the underlyingmutations. In total, vari-
ation in 61 geneswas believed to be responsible for the heart
defects; of these, almost half were genes not previously
implicated in CHD. The results of the screen underscore
the importance of cilia in heart development. Of the 61
genes highlighted by the screen, 34 (including genes needed
in either motile or primary cilia) were part of the ciliome.
Li et al. (2015). Nature 521, 520–524.This Month in Our Sister JournalsSo You Found an Association—What Next?
A genetic association is simply a statistical correlation be-
tween genetic variation and a trait of interest. It is a first
step in discovering the genetic variation that contributes
to trait development. Pinpointing the causal variation
within an associated region that could be millions of
base pairs in size is not straightforward, and fine-mapping
methods can be helpful for highlighting the variation that
should be tested in functional assays. To facilitate this,Chen et al. unified two existing fine-mapping methods
in a general Bayesian framework that, rather than using
the original genotype data, utilizes summary information,
which is often more readily accessible. The authors used
simulations and analysis of real data to illustrate the perfor-
mance of their method in identifying candidate causal
variants for further analysis.
Chen et al. (2015). Genetics. Published online May 6, 2015.
http://dx.doi.org/10.1534/genetics.115.176107.
